+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Host immunologic augmentation for the control of infection



Host immunologic augmentation for the control of infection



Infectious Disease Clinics of North America 10(2): 345-364



The emergence of resistance to pharmacologic antimicrobial agents and the desire to increase chemotherapy dose-intensity have necessitated the search for alternative means to control infectious disease. Enhancement of host immunity against infection has been permitted through the use of hematopoietic growth factors, which can shorten the duration of neutropenia and reduce the risk for bacterial and fungal infections. Hematopoietic growth factor-mobilized hematopoietic stem cells have also proven to be highly efficacious in permitting high-dose chemotherapy. Interferons, immunoregulatory cytokines, immune globulins, and immune lymphocytes also hold promise to enhance host immunity and reduce susceptibility for serious infectious morbidity.

(PDF emailed within 0-6 h: $19.90)

Accession: 046274838

Download citation: RISBibTeXText

PMID: 8803624

DOI: 10.1016/S0891-5520(05)70302-0


Related references

Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells. Journal of the National Cancer Institute 75(4): 703-708, 1985

Immunologic host defense in melanoma: delineation of effector mechanisms involved and of strategies for the augmentation of their efficacy. Journal of Investigative Dermatology 105(1 Suppl): 110s-116s, 1995

Augmentation by lactoferrin of host defense against Candida infection in mice. Lactoferrin: structure, function and applications Proceedings of the 4th International Conference on Lactoferrin: Structure, Function and Applications, held in Sapporo, Japan, 18-22 May 1999: 195-201, 2000

Delayed fungal infection following augmentation mammoplasty in an immunocompetent host. Singapore Medical Journal 48(3): 256-258, 2007

Augmentation of microsporidia adherence and host cell infection by divalent cations. Fems Microbiology Letters 260(2): 143-149, 2006

Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei. Journal of Clinical & Laboratory Immunology 17(2): 91-97, 1985

Augmentation of host resistance against bacterial infection by treatment with leustroducsin B, a new CSF inducer. Microbiology and Immunology 38(9): 741-745, 1994

Ectopic-site filariid infection with immunologic follow-up of the host. Proceedings of the Heartworm Symposium ' 80, Dallas, Texas, 23-24 February 1980: 51-54, 1981

Augmentation of graft vs. host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation (Baltimore) 39(5): 548-553, 1985

Augmentation of host defense against Listeria monocytogenes infection by oral administration with polysaccharide RBS (RON). International Journal of Immunopharmacology 12(4): 373-383, 1990

Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation 39(5): 548-553, 1985

Augmentation of host resistance to Candida albicans infection in ascites tumor-bearing mice. Microbiology and Immunology 36(5): 517-521, 1992

Augmentation of host defense against bacterial infection pretreated intraperitoneally with an alpha-glucan RBS in mice. Immunopharmacology and Immunotoxicology 12(3): 457-477, 1990

Genetically determined defects in host resistance to infection: cellular immunologic aspects. Medical Clinics of North America 53(4): 903-922, 1969

Infection and host responses. Susceptibility of diabetic patients to infections and their immunologic mechanisms. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 71(10): 1368-1370, 1982